NITI Aayog suggests ₹50,000-crore fund for biotech growth
NITI Aayog's proposed ₹50,000-crore BioEconomy Growth Fund, six biotechnology missions, and biomanufacturing push aim to scale India’s bioeconomy under a mission-mode framework through 2035.
- NITI Aayog has proposed a mission-mode biotechnology roadmap with a ₹50,000-crore fund, a production-linked incentive scheme, and six national missions.
- The proposed BioEconomy Growth Fund covers the period 2026-35 and is intended to support biomanufacturing, advanced therapeutics, synthetic biology, fermentation, and diagnostics.
- The Press Information Bureau page says interest for the 2025-26 financial year on Provident Fund deposits was credited in one go to 34 crore EPFO accounts on July 15.
What happened
NITI Aayog has proposed a major bioeconomy roadmap to help India become one of the world’s top three biotechnology powers by 2035. The plan calls for a ₹50,000-crore BioEconomy Growth Fund for 2026-35, a dedicated production-linked incentive scheme for biomanufacturing, and six national biotechnology missions.
The roadmap places biotechnology within a mission-mode policy framework and links it to new financing, regulatory reforms, and coordination across ministries. The proposal also projects the bioeconomy rising from $195.3 billion in 2025 to $691 billion by 2035 and $2.6 trillion by 2047, with more than 30 million high-value jobs.
UPSC can frame the NITI Aayog bioeconomy roadmap as a question on how India can combine science, industrial policy, and regulatory reform to build a globally competitive biotechnology sector. The same source also offers a prelims-linked fact on the Employees' Provident Fund Organisation (EPFO) interest-credit process and the role of the Central Board of Trustees.
Related dispatches
